Back

Possibilites of application of different genetic polymorphisms of apolipoproteins in the assessment of clinical severity, in-hospital and long-term outcomes in patients with myocardial infarction

19 April 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Rapid Fire Session I Secondary Prevention EAPC Premium Access EuroPrevent 2018

About the speaker

Photo
Professor Olga Barbarash

Cuban Regional Clinical Hospital No 1, Krasnodar (Russian Federation)

7 More presentations in this session

Presentation thumbnail
Cost-effectiveness of guideline adherence in coronary patients: results from the EUROASPIRE IV survey - a registry from the european society of cardiology
Doctor D. De Smedt (Ghent, BE)
Abstract Slides Video
Presentation thumbnail
LDL extracellular vesicle coagulation protein levels change after initiation of statin therapy in patients with subclinical atherosclerosis. Findings from the METEOR trial
Ms L. Willemsen (Utrecht, NL)
Abstract
Presentation thumbnail
Relationship between the shift of socioeconomic status and cardiovascular mortality
Doctor J. Sung (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Excess mortality of non-participants indicates that low participation rates in health examination surveys bias population level risk factor estimates
Doctor H. Tolonen (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Multiple vascular endothelial growth factor (-receptor) polymorphisms modify the treatment benefit of ACE-inhibitors on cardiovascular outcome
Ms N. Buljubasic (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid Fire Session I

The Event

Event poster

EuroPrevent 2018

19 April - 21 April 2018
You may be interested in
thumbnail
Congress Presentation
Making personalised prevention everyone's business
thumbnail
Congress Presentation
Should we intervene early in patients with asymptomatic aortic stenosis?
thumbnail
Congress Presentation
Cardiovascular prevention in older adults

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources